Will CSL pay a dividend next year?

Based on earnings estimates, CSL will have a dividend payout ratio of 14.44% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CSL. What is D. Christian Koch's approval rating as Carlisle Companies' CEO?

Where can I buy Carlisle companies stock?

Shares of CSL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Carlisle Companies' stock price today?

Does CSL have a competitive advantage?

Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe. Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of CSL’s competitive advantage.

Who is CSL Limited?

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. Return vs Industry: CSL exceeded the Australian Biotechs industry which returned -10.2% over the past year.